{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:59:03Z","timestamp":1773802743866,"version":"3.50.1"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,29]],"date-time":"2011-12-29T00:00:00Z","timestamp":1325116800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0029778","type":"journal-article","created":{"date-parts":[[2011,12,29]],"date-time":"2011-12-29T21:53:31Z","timestamp":1325195611000},"page":"e29778","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":48,"title":["Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus"],"prefix":"10.1371","volume":"6","author":[{"given":"Justin D.","family":"Hoopes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"Driebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Engelthaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul S.","family":"Keim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan S.","family":"Perelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libin","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory T.","family":"Went","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,12,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.2010.1004","article-title":"Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.","volume":"304","author":"MA Thompson","year":"2010","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/aid.2005.21.343","article-title":"Confronting the emergence of drug-resistant HIV type 1: impact of antiretroviral therapy on individual and population resistance.","volume":"21","author":"ES Daar","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/505147","article-title":"The survival benefits of AIDS treatment in the United States.","volume":"194","author":"RP Walensky","year":"2006","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM199709113371102","article-title":"Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.","volume":"337","author":"RM Gulick","year":"1997","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.","volume":"337","author":"SM Hammer","year":"1997","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ajg.2009.726","article-title":"Lessons from HIV therapy applied to viral hepatitis therapy: summary of a workshop.","volume":"105","author":"A Monto","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"ref7","first-page":"901","article-title":"Update: influenza activity - United States, 2009\u201310 season.","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref8","first-page":"369","article-title":"Update: influenza activity\u2013United States, September 28, 2008\u2013April 4, 2009, and composition of the 2009\u201310 influenza vaccine.","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref9","first-page":"433","article-title":"Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009.","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1128\/JVI.01200-09","article-title":"Zanamivir-resistant influenza viruses with a novel neuraminidase mutation.","volume":"83","author":"AC Hurt","year":"2009","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/AAC.40.1.40","article-title":"Generation and characterization of variants of NWS\/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en.","volume":"40","author":"JL McKimm-Breschkin","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1128\/JVI.72.3.2456-2462.1998","article-title":"Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors.","volume":"72","author":"JL McKimm-Breschkin","year":"1998","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1128\/AAC.49.11.4515-4520.2005","article-title":"Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors.","volume":"49","author":"VP Mishin","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa054512","article-title":"Oseltamivir resistance during treatment of influenza A (H5N1) infection.","volume":"353","author":"MD de Jong","year":"2005","journal-title":"N Engl J Med"},{"key":"ref15","first-page":"969","article-title":"Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis\u2013North Carolina, 2009.","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3201\/eid1502.081031","article-title":"Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007\u201308.","volume":"15","author":"SH Hauge","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.00555-08","article-title":"Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.","volume":"52","author":"TG Sheu","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1128\/AAC.01608-09","article-title":"Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance.","volume":"54","author":"M Okomo-Adhiambo","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJMc1003749","article-title":"Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.","volume":"363","author":"E van der Vries","year":"2010","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1086\/656439","article-title":"Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y\/I223R mutation from a child after prolonged treatment with oseltamivir.","volume":"51","author":"HT Nguyen","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e9332","DOI":"10.1371\/journal.pone.0009332","article-title":"Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro.","volume":"5","author":"JT Nguyen","year":"2010","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1128\/AAC.00476-09","article-title":"Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro.","volume":"53","author":"JT Nguyen","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref23","first-page":"S17","article-title":"Dynamics of HIV-1 and CD4+ lymphocytes in vivo.","volume":"11","author":"AS Perelson","year":"1997","journal-title":"AIDS"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1128\/JVI.59.2.377-383.1986","article-title":"Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1.","volume":"59","author":"JD Parvin","year":"1986","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1128\/JVI.00694-10","article-title":"Viral mutation rates.","volume":"84","author":"R Sanjuan","year":"2010","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1021\/ci800267a","article-title":"Why amantadine loses its function in influenza m2 mutants: MD simulations.","volume":"49","author":"C Laohpongspaisan","year":"2009","journal-title":"J Chem Inf Model"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2006.01.012","article-title":"Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.","volume":"70","author":"NA Ilyushina","year":"2006","journal-title":"Antiviral Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/135965350300800301","article-title":"Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza.","volume":"8","author":"MG Ison","year":"2003","journal-title":"Antivir Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/bmj.324.7340.757","article-title":"Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy.","volume":"324","author":"R Jordan","year":"2002","journal-title":"BMJ"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jama.280.1.35","article-title":"Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up.","volume":"280","author":"RM Gulick","year":"1998","journal-title":"Jama"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1086\/314628","article-title":"The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses.","volume":"179","author":"M Markowitz","year":"1999","journal-title":"J Infect Dis"},{"key":"ref32","first-page":"1","article-title":"Guidelines for Using Antiretroviral Agents Among HIV-Infected Adults and Adolescents.","volume":"51","author":"MFAS Dybul","year":"2002","journal-title":"MMWR Recommendations and Reports"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/AAC.49.2.556-559.2005","article-title":"Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations.","volume":"49","author":"Y Abed","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1128\/JVI.77.15.8418-8425.2003","article-title":"Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors.","volume":"77","author":"M Matrosovich","year":"2003","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1086\/344237","article-title":"Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene.","volume":"186","author":"Y Abed","year":"2002","journal-title":"J Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.drup.2003.12.003","article-title":"Lethal mutagens: broad-spectrum antivirals with limited potential for development of resistance?","volume":"7","author":"MS Freistadt","year":"2004","journal-title":"Drug Resist Updat"},{"key":"ref37","article-title":"Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase.","author":"CL Ward","year":"2008","journal-title":"J Viral Hepat"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1128\/JVI.80.7.3675-3678.2006","article-title":"Comparison of the mutation rates of human influenza A and B viruses.","volume":"80","author":"E Nobusawa","year":"2006","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1128\/JVI.01623-05","article-title":"Kinetics of influenza A virus infection in humans.","volume":"80","author":"P Baccam","year":"2006","journal-title":"J Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1128\/JVI.02078-09","article-title":"Dynamics of influenza virus infection and pathology.","volume":"84","author":"RA Saenz","year":"2010","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/bit.20363","article-title":"Mathematical model of influenza A virus production in large-scale microcarrier culture.","volume":"90","author":"L Mohler","year":"2005","journal-title":"Biotechnol Bioeng"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0042-6822(91)90588-3","article-title":"Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses.","volume":"182","author":"E Nobusawa","year":"1991","journal-title":"Virology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jviromet.2009.09.007","article-title":"Rapid quantification of single-nucleotide mutations in mixed influenza A viral populations using allele-specific mixture analysis.","volume":"163","author":"CM Liu","year":"2010","journal-title":"J Virol Methods"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0029778","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T17:35:29Z","timestamp":1686591329000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0029778"}},"subtitle":[],"editor":[{"given":"Suryaprakash","family":"Sambhara","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,29]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0029778","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,29]]}}}